We are witnessing a significant industrial transformation driven by the adoption of digital tools to manage increasing data volumes and automation to streamline workflows. However, inefficiencies in process development and data management continue to pose major challenges. These challenges are magnified by the complexities of scaling biologics production and ensuring consistency across global teams. Digital tools present an opportunity to improve efficiency and enable remote monitoring of your bioreactor cultures. Introducing BioNsight cloud, a true cloud-based software solution for bioprocess monitoring and analysis. It is fully integrated into the Eppendorf bioprocess control software DASware® control 6 and also features DataHowLab, an innovative AI-enabled analytics solution to save time and resources during process development.
Axplora Group announces €50m expansion of GLP-1 manufacturing site
Latest NewsGerman API and antibody drug conjugate (ADC) CDMO Axplora Group GmbH has announced an investment of €50m in its Mourenx site in Southwest France, securing its position as a key player in the fight against cardiovascular and metabolic diseases.
Ethris GmbH bags US$5m from CEPI
Latest NewsOslo-based Coalition for Epidemic Preparedness Innovations (CEPI) has granted US$5m to RNA formulation specialis Ethris to support studies that demonstrate spray-dried RNA vaccines remain stable at room temperature and are suitable for mucosal delivery.
The European Alliance for the Bioeconomy wants to bring back economic growth
Latest NewsNow that US President Donald Trump has loudly announced his intention to withdraw from the Paris climate targets and refocus the US economy on fossil fuel production, Europe, which is still a leader in the bioeconomy, is sensing an opportunity. A new cluster alliance of 14 production sites wants to advance the high-tech bioeconomy.
Mallia selects Northway to produce alopecia therapy
Latest NewsHair loss therapeutics developer Mallia Therapeutics and Northway Biotech have partners to set up a manufacturing process of soluble CD83 protein to prevent and cure hair loss.
Aplagon secures €7m for APAC development
Latest NewsHelsinki-based Aplagon has secured €7m in financing to advance its therapeutic APAC into Phase 2a clinical trials.
BioNsight® cloud: Effortless from data to insights
ProductsWe are witnessing a significant industrial transformation driven by the adoption of digital tools to manage increasing data volumes and automation to streamline workflows. However, inefficiencies in process development and data management continue to pose major challenges. These challenges are magnified by the complexities of scaling biologics production and ensuring consistency across global teams. Digital tools present an opportunity to improve efficiency and enable remote monitoring of your bioreactor cultures. Introducing BioNsight cloud, a true cloud-based software solution for bioprocess monitoring and analysis. It is fully integrated into the Eppendorf bioprocess control software DASware® control 6 and also features DataHowLab, an innovative AI-enabled analytics solution to save time and resources during process development.
EC launches EU Biotech and Biomanufacturing Hub
Latest NewsOne day after presenting its competition strategy, the EU Commission has launched an EU Biotech and Biomanufacturing Hub. The collection of information is intended to help biotech start-ups navigate through the jungle of EU funding measures and provide access to networks that help with patenting, product authorisation and compliance with EU regulations.
Green Biotech Fund surges past €150M target
Latest NewsDutch venture capital firm Forbion revealed that its BioEconomy Fund I has amassed €164.5m. This surpasses the fund’s initial target of €150m, highlighting the increasing interest from investors in the commercial viability of biotech solutions that tackle worldwide sustainability issues.
FDA greenlights expanded use of Ozempic
Latest NewsThe FDA has approved Novo Nordisk’s blockbuster drug Ozempic (semaglutide) for patients with chronic kidney disease who also have type 2 diabetes.
Systemic Bio wins SLAS Innovation Award 2025
Associations, Latest NewsThis year’s US$10,000 Innovation Award for the most relevant automation technology presentation at SLAS 2025 goes to Taci Pereira, CEO of Systemic Bio from Houston. She prevailed against nine finalists at the important automation conference SLAS 2025 in San Diego.